Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. 0NOVO
0NOVO logo

0NOVO Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

No data

No data

News

moomoo
7.0
02-10moomoo
HIMS & HERS HEALTH STOCKS FALL 3% FOLLOWING NOVO NORDISK'S PATENT INFRINGEMENT LAWSUIT
  • Stock Performance: HIMS & HERS shares have decreased by 3% following a lawsuit from Novonordisk regarding patent infringement.
  • Legal Context: The lawsuit highlights ongoing legal challenges in the pharmaceutical industry, particularly concerning intellectual property rights.
moomoo
7.0
02-09moomoo
NOVO NORDISK SEEKS PERMANENT COURT INJUNCTION AGAINST HIMS FOR SELLING UNAUTHORIZED COMPOUNDED DRUGS IN VIOLATION OF PATENTS AND SEEKS DAMAGES
  • Court Ruling: A court has permanently banned a company from selling unapproved, compounded drugs that infringe on patents.
  • Legal Action: The company is seeking to recover damages related to the infringement of these patents.
moomoo
7.0
02-03moomoo
Obesity Drug Manufacturers and Developers Drop Following Novo Nordisk's Warning of Significant Sales Decline in 2026
  • Market Decline: Obesity drug makers and developers are experiencing a significant decline in sales forecasts for 2026.

  • Novo Nordisk Warning: Novo Nordisk has issued warnings regarding the steep drop in expected sales, indicating potential challenges ahead for the industry.

moomoo
2.0
02-03moomoo
ELI LILLY STOCK FALLS 3% FOLLOWING NOVO NORDISK'S WARNING OF SIGNIFICANT SALES DROP IN 2026
  • Eli Lilly's Stock Performance: Eli Lilly shares fell by 3% following warnings from rival Novonordisk regarding a significant decline in sales expected in 2026.

  • Market Impact: The warning from Novonordisk has raised concerns in the market, particularly affecting Eli Lilly's stock value.

moomoo
4.5
02-03moomoo
NYSE Suspends Trading of Novo Nordisk A/S Due to Pending News at $57.84
  • Financial Overview: The NYSE reported a significant spending amount of $57.84 million.
  • Market Impact: This spending figure may influence market trends and investor sentiment.
Wall Street analysts forecast 0NOVO stock price to rise
0 Analyst Rating
Wall Street analysts forecast 0NOVO stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for (0NOVO) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding 0NOVO

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (0NOVO) stock price today?

The current price of 0NOVO is 0 USD — it has increased 0

What is (0NOVO)'s business?

What is the price predicton of 0NOVO Stock?

Wall Street analysts forecast 0NOVO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 0NOVO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (0NOVO)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (0NOVO)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (0NOVO). have?

(0NOVO) has 0 emplpoyees as of April 03 2026.

What is (0NOVO) market cap?

Today 0NOVO has the market capitalization of 0.00 USD.